Atul Khandekar
Atul Khandekar is COO of SymphonyTech Biologics
Articles
Smritie Sheth;Ravindra Khare;Atul Khandekar;Guljit Chaudhuri;Shilpa Jindani;Narendra Chirmule;Brinda Kakkar;Raman Govindrajan;Smita Kale;V. Premnath;Ranganayaki Nagaraj
February 3rd 2021A task force details its findings of the risks associated with using convalescent plasma using failure mode and effects analysis
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: December 9th 2024 | Updated: December 22nd 2024
Recap Key Industry Trends for Viral Clearance and NGS
Published: December 7th 2024 | Updated: December 22nd 2024
Enhancing Quality Through Training
Published: July 20th 2020 | Updated: December 22nd 2024
Contact BioPharm International Editors
Published: July 19th 2020 | Updated: December 22nd 2024
Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars
